African Health Data Insights
Research, analysis, and practical guides for pharma, CROs, and African digital health teams working with health data across the continent.
Botswana's Healthcare System: From HIV Response to Health System Strength
The Botswana healthcare system has earned global recognition for its HIV/AIDS response, becoming the first African country to offer free antiretroviral therapy in 2002 and the first high-burden country to achieve WHO gold tier status for eliminating mother-to-child HIV transmission. For pharma companies and researchers, it represents one of the continent's most structured health environments.
Egypt's Healthcare System: Infrastructure, Universal Coverage, and Digital Health
Egypt's healthcare system serves over 118 million people and is in the middle of a universal health insurance rollout, an early-stage digital infrastructure build, and pharmaceutical manufacturing expansion, all of which affect the country's health data environment.
Malawi's Healthcare System: Community Health, Data Systems, and Research
The Malawi healthcare system delivers free primary care to over 20 million people through a tiered network of public and faith-based facilities, supported by one of Africa's largest community health worker programmes and a growing digital health infrastructure.
Morocco's Healthcare System: Reform, Coverage, and Pharma Hub Ambitions
The Morocco healthcare system now covers 88 percent of the population through universal insurance, up from 42 percent five years ago, and has Africa's second-largest pharmaceutical manufacturing sector. This profile covers the reforms, infrastructure, disease burden, and digital health progress in the country's health sector.
Tanzania's Healthcare System: Structure, Community Health, and Research Capacity
Tanzania's healthcare system serves over 70 million people through a decentralised public network spanning dispensaries, health centres, and referral hospitals. This profile covers the system's structure, disease burden, community health workforce, digital health platforms, and growing clinical research capacity.
Zambia's Healthcare System: Structure, Challenges, and Digital Health Progress
Zambia's healthcare system serves nearly 22 million people through a tiered public network of hospitals, health centres, and community health posts. This profile examines the country's health financing reforms, disease burden, digital health progress with SmartCare, and growing clinical trial activity.
Zimbabwe's Healthcare System: Resilience, Recovery, and Digital Transformation
The Zimbabwe healthcare system has achieved some of Africa's most striking public health outcomes despite severe economic constraints, including reaching the UNAIDS 95-95-95 HIV targets in 2024. This profile examines the country's health infrastructure, village health worker network, growing digital health capacity, and clinical research institutions.
African Genomics: Why the Continent Holds the Key to Global Drug Development
African genomics research is reshaping drug development. The continent holds more genetic diversity than the rest of the world combined, yet African populations remain dramatically under-represented in global genomic databases and clinical trials.
Clinical Trials in Africa: The Complete Guide for Sponsors and CROs
Clinical trials in Africa offer sponsors access to treatment-naive patient populations, high disease prevalence, and competitive site costs. Success depends on understanding the regulatory environment, site infrastructure, and data systems that vary significantly across the continent.
Digital Health in Africa: Trends, Investment, and Impact
Digital health in Africa is growing faster than any other region, with the market estimated at USD 5.6 billion in 2025 and projected to reach USD 7.6 billion by 2029. This guide covers the investment trends, mobile health adoption, government strategies, and data challenges shaping the continent's health tech sector.
Electronic Health Records in Africa: Adoption, Challenges, and Best Practices
Electronic health records in Africa are expanding rapidly across East and West Africa, with OpenMRS, DHIS2, and national EMR systems now covering millions of patient encounters. Fragmentation, interoperability gaps, and connectivity barriers still limit their research and clinical value.
Ghana's Healthcare System: Infrastructure, NHIS, and Digital Health
Ghana's healthcare system is among West Africa's most structured, anchored by the National Health Insurance Scheme and a tiered public facility network. Coverage gaps, NCD growth, and digital health adoption challenges persist alongside genuine strengths in research and innovation.
Health Data Privacy in Africa: Regulatory Guide for Research and Development
Health data privacy in Africa is governed by a patchwork of national laws, from South Africa's POPIA to Nigeria's NDPA and Kenya's Data Protection Act, that every sponsor, CRO, and health tech company must navigate before accessing or exporting African patient data.
South Africa's Healthcare System: Public, Private, and Digital
South Africa's healthcare system is the continent's most developed, but also its most unequal. Roughly 15 percent of the population in the private sector consumes more resources than the 85 percent relying on public facilities. The National Health Insurance aims to change that.
Uganda's Healthcare System: Structure, Data, and Research Potential
Uganda's healthcare system serves nearly 46 million people through a tiered public network, strong research institutions in HIV and malaria, and a growing digital health infrastructure that has made it an important destination for clinical research.
Real-World Evidence in Drug Development: What It Is and Why It Matters
Real-world evidence is reshaping drug development, from regulatory submissions to post-market surveillance. This guide explains the distinction between RWD and RWE, the regulatory frameworks that govern their use, and why emerging market data represents the next frontier.
What Is Precision Medicine? A Complete Guide
Precision medicine tailors treatment to individual patients based on their genetics, environment, and lifestyle. This guide explains how it works, where it is being applied, and why population diversity is critical to its success.
Ethiopia's Healthcare System: Structure, Disease Burden, and Digital Health
Ethiopia's healthcare system serves approximately 130 million people, the second-largest population in Africa. This guide covers the three-tier delivery system, the Health Extension Programme, digital health progress, and the state of clinical research capacity across the country.
Rwanda's Healthcare System: A Model for Digital Health in Africa
Rwanda went from a destroyed healthcare system in 1994 to 90 percent health insurance coverage and expanding EMR deployment across its public facilities. This guide covers the system's structure, insurance model, digital infrastructure, and what it offers as a research and health data environment.
Kenya's Healthcare System: Infrastructure, Digital Health, and Research Capacity
Kenya operates one of East Africa's most developed healthcare systems, with a devolved structure spanning 47 counties. This guide covers the system's architecture, disease burden, digital health ecosystem, and what makes it one of the continent's strongest markets for clinical research and health data.
Patient Recruitment for Clinical Trials: Strategies That Actually Work
Patient recruitment remains the single largest bottleneck in clinical development. Up to 80 percent of trials fail to meet enrollment timelines. Here are the data-driven strategies that are changing that trajectory.
Healthcare in Nigeria: System Overview, Challenges, and Digital Transformation
Nigeria's healthcare system serves approximately 230 million people through a federation of 36 states, each running its own health infrastructure. This guide covers the system's structure, disease profile, digital health progress, and what the data landscape actually looks like on the ground.
Diversity in Clinical Trials: Why It Matters and How to Achieve It
Clinical trial diversity is no longer optional. Regulatory mandates, scientific evidence, and market access pressures are converging to make inclusive enrollment a strategic imperative for every drug developer.